Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015
Abstract
Authors
W Ansari K Infante
W Ansari K Infante
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now